female pattern hair loss Latest News

Lexington Int’l announces that FDA Marketing Clearance has been granted for the HairMax Advanced 7 and Professional 12, for the treatment of androgenetic alopecia (hereditary hair loss) in females.

Lexington International, LLC is pleased to announce that it has received FDA Marketing Clearance for the HairMax Dual 12 home-use laser phototherapy device for hereditary hair loss in females.

For the first time in twenty three years, a new home-use treatment for female pattern hair loss is available. The HairMax LaserComb Lux 9 has received FDA Clearance for marketing to treat female hair loss and promote hair growth.

At the 2011 American Academy of Dermatology (AAD) Meeting beginning February 4, 2011 the results of a double blind, device controlled clinical study of females with Androgenetic Alopecia treated with the HairMax LaserComb® Lux 9 will be released .

On the average, people shed about 100-150 hairs per day. Unfortunately, about one-third of women suffer from androgenetic alopecia, also known as female pattern alopecia or baldness.

alopecia, Female pattern hair loss, Hair Loss, hair transplant, male pattern hair loss, pattern baldness